| REVIEW ARTICLE |
|
| Year : 2018 | Volume
: 1
| Issue : 1 | Page : 2-9 |
|
|
Current management strategies in gallbladder cancers
Vikas Ostwal1, Sanyo Dsouza1, Shraddha Patkar2, Sherly Lewis3, Mahesh Goel2, Krunal Khobragade2, Anant Ramaswamy1
1 Department of Medical Oncology, TMH, Mumbai, Maharashtra, India
2 Department of Surgical Oncology, TMH, Mumbai, Maharashtra, India
3 Department of Radiation Oncology, TMH, Mumbai, Maharashtra, India
Correspondence Address:
Dr. Anant Ramaswamy
Department of Medical Oncology, Tata Memorial Centre, E. Borges Road, Parel, Mumbai, Maharashtra
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/CRST.CRST_4_18
|
|
|
Gallbladder cancers (GBC) are common in the Indo-Gangetic belt of India. Most consensus guidelines in the West have considered GBC as part of the biliary tract cancer spectrum; however, considering the markedly higher burden of GBC in India, there is a need to have specific management treatment strategies in the Indian scenario. The extent of surgical resections, the use of staging laparoscopies, the optimum adjuvant therapy for resected high-risk GBC (T3 or T4 disease and node-positive disease), as well as the preferred second-line chemotherapeutic regimens for advanced GBC are questions that remain incompletely defined and answered. The current review presents a synopsis of currently available evidence and emerging approaches in the treatment of GBC.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
